Shingles are wicked bad. Latest vaccine gives better protection.
The old shot, Zostavax (from Merck), made with the live shingles virus, has been recommended for those 60 and older since its approval more than a decade ago. Given in a single dose, it reduces the risk of developing shingles by 51 percent, says the CDC.
The new vaccine, Shingrix (from GlaxoSmithKline), without live virus, targets folks 50 and up, and in clinical trials posted a 98 percent effective rate for one year and 85 percent for two years, the company says. It is given in two doses.
Updated 11-25-2017
The old shot, Zostavax (from Merck), made with the live shingles virus, has been recommended for those 60 and older since its approval more than a decade ago. Given in a single dose, it reduces the risk of developing shingles by 51 percent, says the CDC.
The new vaccine, Shingrix (from GlaxoSmithKline), without live virus, targets folks 50 and up, and in clinical trials posted a 98 percent effective rate for one year and 85 percent for two years, the company says. It is given in two doses.
Updated 11-25-2017
The Adult Vaccine Quiz
Easy-to-Read Schedule for Adults, by Health Condition
Easy-to-Read Schedule for Adults, by Age
Adult Immunization Schedule by Medical & Other Indications
Adult Immunization Schedule, by Vaccine and Age Group
RSS Feed